Chinese drug discovery platform QureBio raised corporate funding last week while JD.com and Qi-Anxin Technology Group were among the LPs that helped set up the $470m Shoudu Pan Healthcare Industry Fund.

Funding

Indonesia-based coffeehouse chain operator Kopi Kenangan reached a $96m first close today for its series C funding featuring investors including internet company Kunlun. Investment firm Tybourne Capital Management led the tranche completed at a valuation above $1bn, investing alongside Horizons Ventures, B Capital and Falcon Edge Capital.

China-based drug discovery platform QureBio raised RMB200m ($31m) in a series B round on Thursday led by financial services firm Bank of Communications’ Bocom International unit. Oriza Holdings, Spinnotec, Longmen Capital and…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.
Email LinkedIn